Skip to main content
Log in

Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy) — a morphometric evaluation before and after therapy

  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Summary

A morphometric study was performed on bone marrow infiltrates of non-Hodgkin's lymphomas (B-cell type, low malignancy) to evaluate the content of argyrophilic (reticulin) fibres in the various subtypes before and after therapy. In congruence with the corresponding lymph node lesions, subtypes consisted of lymphocytic lymphoma — chronic lymphocytic leukaemia (CLL,n = 39), centroblastic-centrocytic lymphoma (CB-CC,n = 35), lymphoplasmacytoid immunocytoma (LPI,n = 22) and finally hairy cell leukaemia (HCL,n = 21). In comparison with control specimens, morphometric measurements on trephine biopsies (initial staging procedure) disclosed a borderline or minimal increase in reticulin in CLL and moderate fibrosis in CB-CC and LPI, whereas HCL had the greatest increase in fibres. The marrow surrounding focal or patchy lymphoma infiltrates of CLL and CB-CC displayed no relevant changes in fibre density with respect to the control samples. Following chemotherapy, repeated trephine biopsies (restaging procedure) were obtainable from 38 patients. There was no significant decrease in the fibre content of CLL, CB-CC and LPI infiltrates. In HCL an incomplete reduction was recorded after interferon treatment. So-called benign lymphoid lesions may be distinguished from focal-patchy infiltrates of CB-CC and LPI not only by showing a central localization, but also by the absence of significant amounts of reticulin. However, considering the density of the reticulin fibres, a clear-cut discrimination of these lymphoid aggregates from an early nodal-central growth pattern of CLL is not feasible in many cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bardawil RG, Grovers C, Ratain MJ, Golomb HM, Vardiman JW (1986) Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2-interferon for hairy cell leukemia. Am J Clin Pathol 85:194–201

    Google Scholar 

  • Barosi G, Liberato LN, Costa A, Ascari E (1989) Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia. Blut 58:271–274

    Google Scholar 

  • Bartl R, Frisch B, Burkhardt R, Kettner G, Mahl G, Fateh-Moghadam A, Sund M (1982) Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification and staging. Br J Haematol 51:511–530

    Google Scholar 

  • Bartl R, Frisch B, Burkhardt R, Jäger K, Pappenberger R, Hoffmann-Fezer G (1984) Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol 37:233–254

    Google Scholar 

  • Bartl R, Hansmann ML, Frisch B, Burkhardt R (1988) Comparative histology of malignant lymphomas in lymph node and bone marrow. Br J Haematol 69:229–237

    Google Scholar 

  • Berneman ZN, Gastl G, Gangji D, Camp B van, Jochmans K, Aulitzky W, Flament J, Peetermans ME, Huber C (1986) Treatment of hairy cell leukemia with recombinant alpha 2-interferon. Eur J Cancer Clin Oncol 22:987–990

    Google Scholar 

  • Burke J (1978) The value of the bone marrow biopsy in the diagnosis of hairy cell leukemia. Am J Clin Pathol 70:876–884

    Google Scholar 

  • Burke J, Rappaport H (1984) The diagnosis and differential diagnosis of hairy cell leukemia in bone marrow and spleen. Semin Oncol 11:334–345

    Google Scholar 

  • Burkhardt R, Frisch B, Bartl R (1982) Bone biopsy in haematological disorders. J Clin Pathol 35:257–284

    Google Scholar 

  • Carlo-Stella C, Cazzola M, Barosi G, Dezza L, Meloni F, Pedrazzoli P, Hoelzer D, Ascari E (1987) Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-MK, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia. Blood 70:1014–1019

    Google Scholar 

  • Dixon WJ (1983) BMDP statistical software. University of California Press, Berkeley

    Google Scholar 

  • Faulkner-Jones BE, Howie AJ, Boughton BJ, Franklin IM (1988) Lympoid aggregates in bone marrow: study of eventual outcome. J Clin Pathol 41:768–775

    Google Scholar 

  • Fisher RA (1972) Statistical methods for research workers. Oliver and Boyd, Edinburgh

    Google Scholar 

  • Frisch B, Bartl R (1985) Histology of myelofibrosis and osteomyelosclerosis. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Dekker, New York, pp 51–86

    Google Scholar 

  • Frisch B, Bartl R (1988) Histologic classification and staging of chronic lymphocytic leukemia. A retrospective and prospective study of 503 cases. Acta Haematol (Basel) 79:140–152

    Google Scholar 

  • Frisch B, Bartl R, Burhardt R (1982) Bone marrow biopsy in clinical medicine: an overview. Haematologia 3:245–285

    Google Scholar 

  • Frisch B, Lewis SM, Burkhardt R, Bartl R (1985) Biopsy pathology of bone and bone marrow. Chapman and Hall, London, pp 180–230

    Google Scholar 

  • Ganser A, Carlo-Stella C, Greher J, Volkers B, Hoelzer D (1987) Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood 70:1173–1179

    Google Scholar 

  • Georgii A (1979) Classification of non-Hodgkin lymphomas from biopsies of the bone marrow with special emphasis to their spread. In: Crowther DG (ed) Advances in medical oncology, research and education, vol 7. Leukemia and non-Hodgkin lymphoma. Pergamon Press, Oxford, pp 179–188

    Google Scholar 

  • Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J, Portlock C, Ratain M, Golde D, Vardiman J, Burke JS, Brady J, Bonnem E, Spiegel R (1986) Alpha-2 interferon therapy of hairy cell leukemia: a multicenter study of 64 patients. J Clin Oncol 4:900–905

    Google Scholar 

  • Groopman JE (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92:857–858

    Google Scholar 

  • Groopman JE (1985) Therapeutic options in hairy-cell leukemia. Semin Oncol 12:30–34

    Google Scholar 

  • Hall PA, D'Ardenne AJ, Stansfeld AG (1988) Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma. Histopathology 13:149–160

    Google Scholar 

  • Han T, Barcos M, Emrich L, Ozer H, Gajera R, Gomez GA, Reese PA, Minowada J, Bloom ML, Sadamori N, Sandberg AA, Henderson ES (1984) Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. J Clin Oncol 2:562–570

    Google Scholar 

  • Hashimoto M, Masanori H, Tsukasa S (1957) Lymphoid nodules in human bone marrow. Acta Pathol Jpn 7:33–52

    Google Scholar 

  • Hasselbalch H, Braide I, Lisse I, Röckert L, Swolin B, Carneskog J, Hagberg H, Hippe E, Jensen MK, Lundin P, Malm C, Nielsen B, Rödjer S, Westin J, Zador G (1988) Recombinant interferon-alpha-2b treatment of hairy cell leukaemia: experience with a low-dose schedule. Eur J Haematol 41:438–444

    Google Scholar 

  • Horwitz AL, Hance AJ, Crystal RG (1977) Granulocyte collagenase: selective degradation of type I relative to type III collagen. Proc Natl Acad Sci USA 79:897–901

    Google Scholar 

  • Jamshidi K, Swaim WR (1971) Bone marrow biopsy with unaltered architecture: a new biopsy device. J Lab Clin Med 77:335–342

    Google Scholar 

  • Jansen JTP, De Pauer BE, Holdrinet RSG (1984) Treatment of hairy cell leukaemia with recombinant human alpha 2-interferon. Lancet I:1025–1026

    Google Scholar 

  • Lauria F, Foà R, Raspadori D, Zinzani PL, Buzzi M, Fierro MT, Bonferroni M, Fanin R, Gallizia C, Michieli MG, Degani G, Resegotti L, Tura S (1988) Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN). Eur J Cancer Clin Oncol 24:195–200

    Google Scholar 

  • Lerma-Puertas E, González-Cámpora R, Amérigo-Navarro J, Rubí-Uría J, Galera-Davidson H (1988) Morphometric study of bone marrow in chronic lymphocytic leukemia. Anal Q Cytol Histol 10:28–32

    Google Scholar 

  • Laughlin M, Islam A, Barcos M, Meade P, Ozer H, Gavigan M, Henderson E, Han T (1988) Effect of alpha-interferon therapy on bone marrow fibrosis in hairy cell leukemia. Blood 72:936–939

    Google Scholar 

  • Manoharan A, Pitney WR (1984) Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis. Scand J Haematol 33:453–459

    Google Scholar 

  • McCarthy DM (1985) Fibrosis of the bone marrow: content and causes. Br J Haematol 59:1–7

    Google Scholar 

  • Mehta AB, Baughan ASJ, Catovsky D, Goldman JM, Johnson SAN, Galton DAG (1983) Reversal of marrow fibrosis in acute megakaryoblastic leukemia after remission induction and consolidation chemotherapy followed by bone marrow transplantation. Br J Haematol 53:445–449

    Google Scholar 

  • Montserrat E, Rozman C (1987) Bone marrow biopsy in chronic lymphocytic leukemia: a review of its prognostic importance. Blood Cells 12:315–326

    Google Scholar 

  • Naeim F, Jacobs AD (1985) Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon. Hum Pathol 16:1200–1205

    Google Scholar 

  • Navone R, Colombano MT (1984) Histopathological trephine biopsy findings of ‘dry tap’ bone marrow aspirations. Appl Pathol 2:264–271

    Google Scholar 

  • Navone R, Valpreda M, Pich A (1985) Lymphoid nodules and nodular lymphoid hyperplasia in bone marrow biopsies. Acta Haematol (Basel) 74:19–22

    Google Scholar 

  • Neumann HA, Fauser AA (1982) Effect of interferon on pluripotential hematopoietic progenitors (CFU-GEMM) derived from human bone marrow. Exp Hematol 10:587–590

    Google Scholar 

  • Oblon DJ, Elvenbein GJ, Braylam RC, Jones J, Weiner RS (1983) The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Exp Hematol 11:681–685

    Google Scholar 

  • Orfao A, Gonzalez M, San Miguel J, Rios A, Caballero MD, Sanz M, Jose-Calmuntia M, Galindo P, Lopez-Borrasca A (1988) Bone marrow histopathologic patterns and immunologic phenotype in B-cell chronic lymphocytic leukaemia. Blut 57:19–23

    Google Scholar 

  • Orfao A, Gonzalez M, San Miguel J, Rios A, Canizo MC, Hernandez J, Maricato ML, Lopez-Borrasca A (1989) B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features. Am J Hematol 31:26–31

    Google Scholar 

  • Pangalis GA, Roussou PA, Kittas C, Kokkinou S, Fessas P (1987) B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients. Experience from a single hematology unit. Cancer 59:767–771

    Google Scholar 

  • Paoletti M, Bitter MA, Vardiman JW (1988) Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features. Clin Lab Med 8:179–195

    Google Scholar 

  • Parmeggiani L, Ferrant A, Rodhain J, Michaux JL, Sokal G (1987) Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia. Eur J Haematol 39:228–232

    Google Scholar 

  • Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU (1984) Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 310:15–18

    Google Scholar 

  • Ratain MJ, Golomb HM, Vardiman JW, Westbrook CA, Barker C, Hooberman A, Bitter MA, Daly K (1988) Relapse after interferon alpha-2b therapy for hairy cell leukemia: analysis of prognostic variables. J Clin Oncol 6:1714–1721

    Google Scholar 

  • Rozman C, Montserrat E, Rodríguez-Fernández JM, Ayats R, Vallespí T, Parody R, Ríos A, Prados D, Morey M, Gomis F, Alcalá A, Gutiérrez M, Maldonado J, González C, Giralt M, Hernández-Nieto L, Cabrera A, Fernández-Rañada JM (1984) Bone marrow histologie pattern — the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 64:642–648

    Google Scholar 

  • Schaefer HE (1984) How to fix, decalcify and stain paraffin embedded bone marrow biopsies. In: Lennert K, Hübner K (eds) Pathology of the bone marrow. Fischer, Stuttgart, pp 6–9

    Google Scholar 

  • Stansfeld AG, Diebold J, Kapanci Y, Kelényi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, Unnik JAM van, Wright DH (1988) Updated Kiel classification for lymphomas. Lancet I:292–293

    Google Scholar 

  • Vykoupil KF, Georgii A (1984) Non-Hodgkin's lymphomas in bone marrow: diagnosis according to Kiel Classification and their growth pattern and relations to survival. In: Lennert K, Hübner K (eds) Pathology of the bone marrow. Fischer, Stuttgart, pp 339–346

    Google Scholar 

  • Vykoupil KF, Thiele J, Georgii A (1976) Hairy cell leukemia, bone marrow findings in 24 patients. Virchows Arch [A] 370:273–289

    Google Scholar 

  • Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York

    Google Scholar 

  • Worman CP, Catovsky D, Bevan PC, Camba L, Joyner M, Green PJ, Williams JH, Bottomley JM, Gordon-Smith EC, Cawley JC (1985) Interferon is effective in hairy-cell leukaemia. Br J Haematol 60:759–763

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, J., Langohr, J., Skorupka, M. et al. Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy) — a morphometric evaluation before and after therapy. Vichows Archiv A Pathol Anat 417, 485–492 (1990). https://doi.org/10.1007/BF01625728

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01625728

Key words

Navigation